ATAI Life Sciences N.V. (ATAI) Income Statement (2025 - 2026)
Income Statement report data from Mar 31, 2025 to Mar 31, 2026 for ATAI Life Sciences N.V. (ATAI).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Mar 31, 2025 | |
|---|---|---|
Revenue and COGS | ||
Total Revenue | 950K (-39.10%) | 1.56M |
Operating Expenses | ||
Research And Development | 600K (-94.70%) | 11M |
Selling General And Administrative | 14M (+36.23%) | 11M |
Operating Expenses | 32M (+45.28%) | 22M |
Depreciation And Amortization | 170K (-22.73%) | 220K |
Operating Income | ||
Operating Income | -30.90M (+51.69%) | -20.37M |
Ebit | -30.90M (+51.69%) | -20.37M |
EBITDA | -30.73M (+52.51%) | -20.15M |
Other Income / Expenses | ||
Interest Income | 80K (-57.89%) | 190K |
Interest Expense | - | 900K |
Net Interest Income | 80K (-57.89%) | 190K |
Other Non Operating Income | 90K | - |
Net Income | ||
Income Before Tax | -29.78M (+13.19%) | -26.31M |
Income Tax Expense | 20K (-87.50%) | 160K |
Net Income From Continuing Operations | -29.78M (+12.67%) | -26.43M |
Net Income | -29.78M (+12.67%) | -26.43M |
Comprehensive Income Net Of Tax | -29.45M (+8.63%) | -27.11M |